BrePco Biopharma and Aspire Pharma announce UK license and CMC development agreement for Neoatricon

June 25, 2019 by admin

Attachments

  1. AspireBPCO press release June 25 (22.4 KiB)
    undefined

No Comments

No comments yet.

Sorry, the comment form is closed at this time.